{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T04:18:01Z","timestamp":1745122681932,"version":"3.40.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04228-5","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T19:11:52Z","timestamp":1745089912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferritin levels in scarring and nonscarring alopecia: a cross-sectional study from the All of Us database"],"prefix":"10.1007","volume":"317","author":[{"given":"Shanelle","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle Carolina","family":"Mora Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Puerta Durango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charissa","family":"Obeng-Nyarko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"4228_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.12788\/cutis.0837","volume":"112","author":"D Zhang","year":"2023","unstructured":"Zhang D, LaSenna C, Shields BE (2023) Serum ferritin levels: a clinical guide in patients with hair loss. Cutis 112:62\u201367. https:\/\/doi.org\/10.12788\/cutis.0837","journal-title":"Cutis"},{"issue":"4","key":"4228_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/tcmj.tcmj_95_23","volume":"35","author":"CS Lin","year":"2023","unstructured":"Lin CS, Chan LY, Wang JH, Chang CH (2023) Diagnosis and treatment of female alopecia: focusing on the iron deficiency-related alopecia. Tzu Chi Med J 35(4):322\u2013328. https:\/\/doi.org\/10.4103\/tcmj.tcmj_95_23","journal-title":"Tzu Chi Med J"},{"issue":"3","key":"4228_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5114\/ada.2020.96251","volume":"37","author":"F Tamer","year":"2020","unstructured":"Tamer F, Yuksel ME, Karabag Y (2020) Serum ferritin and vitamin D levels should be evaluated in patients with diffuse hair loss prior to treatment. Postepy Dermatol Alergol 37(3):407\u2013411. https:\/\/doi.org\/10.5114\/ada.2020.96251","journal-title":"Postepy Dermatol Alergol"},{"key":"4228_CR4","unstructured":"World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. April 21, 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240000124. Accessed April 28, 2024."},{"issue":"3","key":"4228_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/1346-8138.17080","volume":"51","author":"DA Yu","year":"2024","unstructured":"Yu DA, Kim SR, Cho SI, Kwon O (2024) Endocrine and metabolic comorbidities in primary cicatricial alopecia: a nationwide population-based study. J Dermatol 51(3):429\u2013440. https:\/\/doi.org\/10.1111\/1346-8138.17080","journal-title":"J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04228-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T19:11:53Z","timestamp":1745089913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4228"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04228-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Elbuluk has served as a consultant, advisory board member, and\/or speaker for Avita, Incyte, VisualDx, La Roche Posay, Beiersdorf, Allergan, Eli Lilly, Galderma, Pfizer, Takeda, Abbvie, Janssen, Sanofi, L\u2019Oreal, McGraw Hill, Dior, Medscape, and Canfield. She has grant funding from Pfizer, has received royalties from McGraw-Hill and has stock options in VisualDx.  Dr. Taylor has been a speaker for Beiersdorf, LivDerm, L'Oreal USA, MedScape, and MJH LifeSciences. She is on the advisory board for Abbvie, Arcutis, Avita Medical, Beiersdorf, Biorez, Bristol Myers Squibb, Cara Therapeutics, Dior, Eli Lilly, EPI Health, Evolus, Galderma, Hugel, J&J, L\u2019Oreal USA, MedScape, Pfizer, Regeneron\/Sanofi, Scientis US, UCB, and Vichy. She is a board member for Mercer Strategies. She has received royalties from McGraw-Hill book royalties. She does contracted research with Allergan Aesthetics, Concert Pharmaceuticals, Croma-Pharma GmbH, Eli Lilly, Pfizer. She has ownership interest in Armis Scientific, GloGetter, and Piction Health. The remaining authors have no disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approvement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}],"article-number":"730"}}